Table 2.
Utilization of Cessation Programs and 7-Day and 30-Day Point Prevalence Abstinence by Study Arm and Number of TTA Sessionsa
| Intervention (%) (n = 121) | Control (%) (n = 129) | cOR (95% CI)b | aOR (95% CI)c | aOR (95% CI)c 1 TTA session (n = 34) | aOR (95% CI)c >1 TTA session (n = 87) | |
|---|---|---|---|---|---|---|
| Utilization | 29.8 | 14.7 | 2.40 (1.14–5.05) | 2.14 (0.93–4.91) | 0.78 (0.23–2.20) | 2.80 (1.07–7.29) |
| Abstinence | ||||||
| 7-day | 16.5 | 10.1 | 1.90 (1.35–2.68) | 2.60 (1.72–3.94) | 2.05 (0.93–4.51) | 2.66 (1.71–4.16) |
| 30-day | 14.9 | 7.8 | 2.29 (1.29–4.04) | 2.98 (1.56–5.68) | 2.78 (1.30–5.95) | 3.06 (1.44–6.51) |
TTA = Tobacco Treatment Advocate.
aThe control group served as the reference category for all analyses.
bcOR: crude odds ratio; CI: confidence interval.
caOR: adjusted odds ratio, using propensity score (see Methods).